KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Cash & Equivalents: 2011-2024

Historic Cash & Equivalents for Zoetis (ZTS) over the last 14 years, with Dec 2024 value amounting to $2.0 billion.

  • Zoetis' Cash & Equivalents rose 21.59% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 21.59%. This contributed to the annual value of $2.0 billion for FY2024, which is 2.65% down from last year.
  • Per Zoetis' latest filing, its Cash & Equivalents stood at $2.0 billion for FY2024, which was down 2.65% from $2.0 billion recorded in FY2023.
  • In the past 5 years, Zoetis' Cash & Equivalents registered a high of $3.6 billion during FY2020, and its lowest value of $2.0 billion during FY2024.
  • For the 3-year period, Zoetis' Cash & Equivalents averaged around $2.5 billion, with its median value being $2.0 billion (2023).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 86.35% in 2020, then tumbled by 43.00% in 2023.
  • Zoetis' Cash & Equivalents (Yearly) stood at $3.6 billion in 2020, then declined by 3.30% to $3.5 billion in 2021, then climbed by 2.75% to $3.6 billion in 2022, then plummeted by 43.00% to $2.0 billion in 2023, then fell by 2.65% to $2.0 billion in 2024.